IRWD Ironwood Pharmaceuticals, Inc.

NASDAQ
$3.77

Ironwood Pharmaceuticals, Inc. (IRWD) is confirmed to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $0.30 per share.

Ironwood Pharmaceuticals Beat Consensus Estimates, Raises Guidance
Thursday, November 5, 2026 · 7:05 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:05 AM ET
Earnings Whisper
-
vs $0.30
Rev est $149.28M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.02

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.